AI‑Driven Virtual Screening Expands Chemical Space Exploration

Henrydixon31 Jul, 2025Health

AI-based virtual screening platforms rapidly analyze chemical libraries, using advanced models to predict binding affinity, off-target risks, and synthetic accessibility, drastically cutting discovery timelines. Integrated with robust biological validation and iterative feedback from experimental data, these methods improve the quality and speed of hit-to-lead progression. The modern workflow combines AI, DEL technologies, and experimental verification, enabling efficient, adaptive, and high-quality drug discovery pipelines.